Safety study of EDP-978 in healthy adults
Part of Immune system & allergy, Skin clinical trials.
This is an early-stage study testing a new experimental drug called EDP-978 in healthy volunteers to see if it is safe and how the body processes it. Researchers will give participants single or multiple doses and monitor for side effects and how the drug moves through the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old and in generally good health
- You cannot be pregnant, nursing, or planning to become pregnant during the study
- You must not have HIV, hepatitis B, hepatitis C, or active COVID-19
- You cannot smoke or have used tobacco in the past 3 months
- You must not use recreational drugs or have a history of heavy alcohol use
- You cannot have had recent surgery on your stomach, intestines, or gallbladder that might affect how your body absorbs medicine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called HRS-3095 in healthy people to check its safety and how the body handles it. It may help find the right dose for future studies.
This study tests an experimental capsule (HS-10561) to see if it is safe and works for people with chronic spontaneous urticaria, which causes hives and itching without a clear trigger. If you have had hives for at least 6 months, you might be able to join.
This trial tests a new medicine called BBT001 for people with chronic spontaneous urticaria (long-lasting hives without a known cause). It aims to see if the drug is safe and helps reduce itching and hives.
This trial tests a new drug, GTX-B001, in healthy people and those with a type of hives called chronic inducible urticaria (specifically cold-induced or scratch-induced hives). The goal is to see if it's safe and helps control symptoms that don't respond well to standard antihistamines.
This trial tests a new injectable medicine (JYB1904) to see if it can reduce itching and hives better than standard antihistamines alone. If you have chronic hives with no clear cause and still get symptoms despite taking antihistamines, this study may be an option for you.
This study tests a new investigational drug, called HRS-8797, in healthy people to see how safe it is and how the body processes it. It's an early-phase trial, so you may not directly benefit, but your participation can help find new treatments for future patients.
Hear when a new Chronic Inducible Urticaria trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.